Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D1 receptor agonist

Neuropharmacology

Volumn 50, Issue 8, 2006, Pages 991-997

  Shuto, Takahide ^a,b   Kuroiwa, Mahomi ^a,b   Hamamura, Mitsuko ^a   Yabuuchi, Kenichi ^a   Shimazoe, Takao ^a   Watanabe, Shigenori ^a   Nishi, Akinori ^b   Yamamoto, Tsuneyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dopamine D1 agonist; Dopamine release; Locomotor activity; Methamphetamine; Sensitization

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; METHAMPHETAMINE; PSYCHOSTIMULANT AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG EFFECT; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSAL REACTION; SENSITIZATION; TREATMENT DURATION;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; ELECTROCHEMISTRY; MALE; METHAMPHETAMINE; MOTOR ACTIVITY; RATS; RATS, WISTAR;

EID: 33646905401     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2006.01.009     Document Type: Article

References (41)

1. Akimoto K., Hamamura T., Kazahaya Y., Akiyama K., and Otsuki S. Enhanced extracellular dopamine level may be the fundamental neuropharmacological basis of cross-behavioral sensitization between methamphetamine and cocaine-an in vivo dialysis study in freely moving rats. Brain Res. 507 (1990) 344-346
2. Arai I., Shimazoe T., Yoshimatsu A., Inoue H., Shibata S., and Watanabe S. Vulnerability of synaptic plasticity in the striatum of methamphetamine-sensitized rats. Jpn. J. Pharmacol. 78 (1998) 105-108
3. Bibb J.A., Snyder G.L., Nishi A., Yan Z., Meijer L., Fienberg A.A., Tsai L.H., Kwon Y.T., Girault J.A., Czernik A.J., Huganir R.L., Hemmings Jr. H.C., Nairn A.C., and Greengard P. Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature 402 (1999) 669-671
4. Bibb J.A., Chen J., Taylor J.R., Svenningsson P., Nishi A., Snyder G.L., Yan Z., Sagawa Z.K., Ouimet C.C., Nairn A.C., Nestler E.J., and Greengard P. Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 410 (2001) 376-380
5. Crawford C.A., Drago J., Watson J.B., and Levine M.S. Effects of repeated amphetamine treatment on the locomotor activity of the dopamine D1A-deficient mouse. Neuroreport 8 (1997) 2523-2527
6. Crawford C.A., Choi F.Y., Kohutek J.L., Yoshida S.T., and McDougall S.A. Changes in PKA activity and Gs alpha and Golf alpha levels after amphetamine- and cocaine-induced behavioral sensitization. Synapse 51 (2004) 241-248
7. Graybiel A.M., Moratalla R., and Robertson H.A. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 6912-6916
8. Hamamura T., Akiyama K., Akimoto K., Kashihara K., Okumura K., Ujike H., and Otsuki S. Co-administration of either a selective D1 or D2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis. Brain Res. 546 (1991) 40-46
9. Henry D.J., and White F.J. Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens. J. Pharmacol. Exp. Ther. 258 (1991) 882-890
10. Hyman S.E., and Malenka R.C. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat. Rev. Neurosci. 2 (2001) 695-703
11. Kalivas P.W., and Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Brain Res. Rev. 16 (1991) 223-244
12. Karler R., Calder L.D., and Turkanis S.A. DNQX blockade of amphetamine behavioral sensitization. Brain Res. 552 (1991) 295-300
13. King G.R., Joyner C., and Ellinwood Jr. E.H. Continuous or intermittent cocaine administration: effects of amantadine treatment during withdrawal. Pharmacol. Biochem. Behav. 47 (1994) 451-457
14. King G.R., Joyner C., and Ellinwood Jr. E.H. Continuous or intermittent cocaine administration: effects of flupenthixol treatment during withdrawal. Pharmacol. Biochem. Behav. 49 (1994) 883-889
15. Kuribara H., and Tadokoro S. Effects of YM-09151-2, a potent and selective dopamine D2 antagonist, on the ambulation-increasing effect of methamphetamine in mice. Jpn. J. Pharmacol. 52 (1990) 489-492
16. Kuribara H., and Uchihashi Y. Dopamine antagonists can inhibit methamphetamine sensitization, but not cocaine sensitization, when assessed by ambulatory activity in mice. J. Pharm. Pharmacol. 45 (1993) 1042-1045
17. Kuribara H., and Uchihashi Y. Effects of dopamine antagonism on methamphetamine sensitization: evaluation by ambulatory activity in mice. Pharmacol. Biochem. Behav. 47 (1994) 101-106
18. Levy A.D., Kim J.J., and Ellison G.D. Chronic amphetamine alters D-2 but not D-1 agonist-induced behavioral responses in rats. Life Sci. 43 (1988) 1207-1213
19. Li Y., White F.J., and Wolf M.E. Pharmacological reversal of behavioral and cellular indices of cocaine sensitization in the rat. Psychopharmacology (Berl.) 151 (2000) 175-183
20. Mark K.A., Soghomonian J.J., and Yamamoto B.K. High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity. J. Neurosci. 24 (2004) 11449-11456
21. Mattingly B.A., Hart T.C., Lim K., and Perkins C. Selective antagonism of dopamine D1 and D2 receptors does not block the development of behavioral sensitization to cocaine. Psychopharmacology (Berl.) 114 (1994) 239-242
22. McCreary A.C., and Marsden C.A. Cocaine-induced behaviour: dopamine D1 receptor antagonism by SCH 23390 prevents expression of conditioned sensitisation following repeated administration of cocaine. Neuropharmacology 32 (1993) 387-391
23. Nestler E.J. Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. 2 (2001) 119-128
24. Nestler E.J., Hyman S.E., and Malenka R.C. Molecular Neuropharmacology: A Foundation for Clinical Neuroscience (2001), McGraw-Hill Medical, New York
25. Nishi A., Bibb J.A., Snyder G.L., Higashi H., Nairn A.C., and Greengard P. Amplification of dopaminergic signaling by a positive feedback loop. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 12840-12845
26. Pierce R.C., and Kalivas P.W. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine. J. Pharmacol. Exp. Ther. 275 (1995) 1019-1029
27. Richtand N.M., Kelsoe J.R., Kuczenski R., and Segal D.S. Quantification of dopamine D1 and D2 receptor mRNA levels associated with the development of behavioral sensitization in amphetamine treated rats. Neurochem. Int. 31 (1997) 131-137
28. Robinson T.E., and Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. 396 (1986) 157-198
29. Saklayen S.S., Mabrouk O.S., and Pehek E.A. Negative feedback regulation of nigrostriatal dopamine release: mediation by striatal D1 receptors. J. Pharmacol. Exp. Ther. 311 (2004) 342-348
30. Samejima K., Ueda Y., Doya K., and Kimura M. Representation of action-specific reward values in the striatum. Science 310 (2005) 1337-1340
31. Self D.W., Barnhart W.J., Lehman D.A., and Nestler E.J. Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists. Science 271 (1996) 1586-1589
32. Shishido T., Watanabe Y., Suzuki H., Kato K., Niwa S., Hanoune J., and Matsuoka I. Effects of repeated methamphetamine administration on dopamine D1 receptor, D2 receptor and adenylate cyclase type V mRNA levels in the rat striatum. Neurosci. Lett. 222 (1997) 175-178
33. Sorg B.A., Li N., and Wu W.R. Dopamine D1 receptor activation in the medial prefrontal cortex prevents the expression of cocaine sensitization. J. Pharmacol. Exp. Ther. 297 (2001) 501-508
34. Tella S.R. Differential blockade of chronic versus acute effects of intravenous cocaine by dopamine receptor antagonists. Pharmacol. Biochem. Behav. 48 (1994) 151-159
35. Ujike H., Akiyama K., Nishikawa H., Onoue T., and Otsuki S. Lasting increase in D1 dopamine receptors in the lateral part of the substantia nigra pars reticulata after subchronic methamphetamine administration. Brain Res. 540 (1991) 159-163
36. Ujike H. Advanced findings on the molecular mechanisms for behavioral sensitization to psychostimulants. Nippon Yakurigaku Zasshi 117 (2001) 5-12
37. Vanderschuren L.J., and Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl.) 151 (2000) 99-120
38. Vezina P., and Stewart J. The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine. Brain Res. 499 (1989) 108-120
39. White F.J., Joshi A., Koeltzow T.E., and Hu X.T. Dopamine receptor antagonists fail to prevent induction of cocaine sensitization. Neuropsychopharmacology 18 (1998) 26-40
40. Xu M., Guo Y., Vorhees C.V., and Zhang J. Behavioral responses to cocaine and amphetamine administration in mice lacking the dopamine D1 receptor. Brain Res. 852 (2000) 198-207
41. Yoshimatsu A., Shimazoe T., Kawashimo A., Shuto T., Doi Y., Fukumoto T., and Watanabe S. Effects of adenosine A1- and A2A-receptor agonists on enhancement of dopamine release from the striatum in methamphetamine-sensitized rats. Jpn. J. Pharmacol. 86 (2001) 254-257